Latest News-SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD. Mediaroom_Page

Lianhua Qingwen Capsules Selected into Home-based Therapeutic Regimen for Mildly Symptomatic COVID-19 Patients in Cambodia

PHNOM PENH, Cambodia, July 14, 2021 /PRNewswire/ -- The Ministry of Health of Cambodia released a h...

2021-07-14 17:32 1414

Lianhua Qingwen Granted Market Access as Medicine in Ukraine: Yiling Pharmaceutical

SHIJIAZHUANG, China, June 29, 2021 /PRNewswire/ -- Yiling Pharmaceutical disclosed in a statement o...

2021-06-29 16:41 2531

New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19

BEIJING, May 6, 2021 /PRNewswire/ -- Recently, new progress has been made in the study of the pharm...

2021-05-06 07:46 6520

New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19

Yiling Pharmaceutical doubled its performance through innovation in 2020

SHIJIAZHUANG, China, April 12, 2021 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) released its ...

2021-04-12 17:07 4655

Market of TCM Lianhua Qingwen Enlarged with Kenya's Approval

SHIJIAZHUANG, China, March 16, 2021 /PRNewswire/ -- In an announcement published by Yiling Pharmace...

2021-03-16 20:20 1848

New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19

SHIJIAZHUANG, China, Feb. 23, 2021 /PRNewswire/ -- Recently, Prof. Caisheng Wu and Prof.Yifeng Chai...

2021-02-23 17:05 2626

Yiling Pharma expects to double its YoY net profit in 2020

SHIJIAZHUANG, China, Jan. 6, 2021 /PRNewswire/ -- Yiling Pharmaceutical, a Shenzhen stock market li...

2021-01-06 16:55 6900

Yiling Pharmaceutical: TCM Lianhua Qingwen Obtained Access to Zimbabwe

SHIJIAZHUANG, China, Dec. 17, 2020 /PRNewswire/ -- Yiling Pharmaceutical discloses on Wednesday tha...

2020-12-17 09:23 3589

TCM Lianhua Qingwen's Access to Russian Market Marks Its Global Expansion

SHIJIAZHUANG, China, Nov. 5, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) discloses that ...

2020-11-05 14:08 8067

Yiling Pharmaceutical: Revenue and Net Profit Attributable to the Parent Company for the First Three Quarters Already Exceeded the Full Year 2019

SHIJIAZHUANG, China, Oct. 28, 2020 /PRNewswire/ -- On October 27, Yiling Pharmaceutical (002603.SZ)...

2020-10-28 17:04 6582

TCM Lianhua Qingwen Capsule approved for registration in Mauritius

SHIJIAZHUANG, China, Sept. 22, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd. (SHE: 002603) a...

2020-09-22 15:21 1903

Preparation products of Yiling Pharma approved by FDA for launch in the US market

SHIJIAZHUANG, China, Sept. 19, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd. announced on Fr...

2020-09-19 19:14 2747

Yiling Pharmaceutical Reports 52.75% YOY Growth in R&D Investment, Boosting the Company's High Quality Development

SHIJIAZHUANG, China, Aug. 28, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) on Thursday pu...

2020-08-28 18:27 11636

TCM Lianhua Qingwen Capsule approved for registration in the Philippines

SHIJIAZHUANG, China, Aug. 11, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd.announced on Mond...

2020-08-11 17:31 4240

Sales of Cardio-Cerebrovascular Products and Lianhua Qingwen Surge, Yiling Pharmaceutical Predicting a 50% Increase in Half-year Net Profit

SHIJIAZHUANG, China, July 13, 2020 /PRNewswire/ -- In the evening of July 12, Yiling Pharmaceutical...

2020-07-13 12:25 12803

Yiling Pharmaceutical Lianhua Qingwen Capsule Extends Overseas Footprint in Southeast Asia

SHIJIAZHUANG, China, July 1, 2020 /PRNewswire/ -- Following Thailand, Singapore andIndonesia, Yilin...

2020-07-01 20:33 8922

Lianhua Qingwen Receives Product Listing Approval from Singapore HSA

SHIJIAZHUANG, China, May 7, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) announced that i...

2020-05-07 15:14 63014